Cargando…

Eculizumab as a bridge to immunosuppressive therapy in severe cold agglutinin disease of anti-Pr specificity

Severe cold agglutinin disease with hemodynamic compromise requires rapid stabilization of the autoimmune hemolytic anemia as a bridge to the immunosuppressive effect of rituximab. Herein, we describe eculizumab treatment of severe complement-mediated hemolysis in a patient whose hemodynamic status...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro, Roman, Chin-Yee, Ian, Lam, Selay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4641479/
https://www.ncbi.nlm.nih.gov/pubmed/26576277
http://dx.doi.org/10.1002/ccr3.399

Ejemplares similares